Jun 13, 2025 — Retatrutide is a weight-loss medication that's in development. It acts like three different natural hormones. This triple action may help ...
by V Katsi · 2025 — Retatrutide is a synthetic peptide acting as an agonist of GLP-1, GIP, and glucagon receptors (Figure 1). Retatrutide's engineering allows it to ...
Sep 17, 2025 — Retatrutide peptide is an unregulated research chemical powder for laboratory research purposes only which is not a therapeutic treatment and is ...
by AM Jastreboff · 2023 · Cited by 902 — Retatrutide (LY3437943) is an agonist of the glucose-dependent insulinotropic polypeptide, glucagon-like peptide 1, and glucagon recept
by T Abdul-Rahman · 2024 · Cited by 14 — Retatrutide is a single peptide that consists of 39 amino acids engineered from a GIP peptide backbone to stimulate GLP-1, GIP, and GCG
Oct 15, 2024 — Retatrutide is a new peptide therapy aimed at treating obesity and type 2 diabetes. It works by activating three hormone receptors: GLP-1, GIP, ...
Nov 18, 2025 — Yes, retatrutide is a single, synthetic peptide that targets the receptors of GLP-1, GIP, and glucagon to suppress appetite, slow digestion, ...
This substance record has relationships which can be visualized as a network with other substance records. A simplified representation of that network can be ...
Retatrutide binds human GCGR, GIPR, and GLP-1R with EC50 values of 5.79, 0.0643 and 0.775 nM, respectively. Retatrutide can be used for the research of obesity.
Retatutride is a synthetic peptide engineered to bind and activate glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and ...